TRPC1 and colonic neoplasm: They demonstrate that reducing the expression of TRPC1 inhibits migration of the HCT-116 colon cancer cell line by disrupting the complex formation of Ca2+-activated K+ channels (SK3), ORAI1, and TRPC1 in the lipid rafts [44].